| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $103.7M | — | +16.9% |
| Cost of Revenue | $49.7M | — | +8.4% |
| R&D Expense | $17.1M | — | -19.6% |
| SG&A Expense | $69.7M | — | +24.1% |
| Operating Income | -$32.9M | — | +5.0% |
| Pre-tax Income | -$30.3M | — | +3.9% |
| Income Tax | $253K | — | +160.8% |
| Net Income | -$30.5M | — | +3.4% |
| EPS (Basic) | -$0.50 | — | +5.7% |
| EPS (Diluted) | -$0.50 | — | +5.7% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $148.6M | -18.8% | -32.9% |
| Short-term Investments | $49.4M | -0.1% | -0.1% |
| Accounts Receivable | $50.1M | -12.2% | +27.3% |
| Inventory | $32.9M | +16.3% | +40.0% |
| Current Assets | $303.9M | -8.7% | -12.0% |
| Total Assets | $638.1M |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$24.8M | — | -15.8% |
| Capital Expenditures | $10.0M | — | +339.8% |
| Investing Cash Flow | -$9.9M | — | -546.7% |
| Financing Cash Flow | $298K | — | -98.3% |
| Free Cash Flow | -$34.8M | — | -46.8% |
| +4.8% |
| Current Liabilities | $80.4M | -12.0% | +15.5% |
| Total Liabilities | $182.0M | +7.7% | +19.2% |
| Stockholders' Equity | $456.1M | -3.6% | +0.0% |